Stockreport

Prelude Therapeutics GAAP EPS of -$1.29 misses by $0.04, revenue of $12.14M [Seeking Alpha]

Incyte Corporation  (INCY) 
Last incyte corporation earnings: 2/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: incyte.com/ir/investor-overview.aspx
PDF Prelude climbs as FDA clears study for Incyte-partnered cancer candidate Seeking Alpha's Quant Rating on Prelude Therapeutics Historical earnings data for Prelude T [Read more]